Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02199678 · ClinicalTrials.gov registry record · Phase 2

A Study to Assess the Analgesic Properties of a Sublingual Wafer Formulation of Ketamine Following Third Molar Extraction

A Phase 2 study of Pain, sponsored by Lotus Clinical Research.

Completed
Registry status
Phase 2
Development phase
120
Enrollment target
2
Study locations

NCT02199678 is a Phase 2 study of Pain that has completed, run by Lotus Clinical Research. The registered enrollment target is 120 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (61% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02199678, a Phase 2 study of Pain, has completed, sponsored by Lotus Clinical Research.

COMPLETED
Registry status
Phase 2
Development phase
120 participants
Enrollment target
2
Study locations

Study Summary

This is a Phase 2, randomized, multicenter, parallel group, double-blind, dose-ranging, placebo-controlled evaluation of the analgesic efficacy, safety and pharmacokinetics of ketamine sublingual wafer in adult subjects who experience post operative pain after undergoing third molar extraction.

Conditions Studied

Pain

Interventions

  • DRUG Placebo
  • DRUG ketamine 25 mg
  • DRUG ketamine 35 mg
  • DRUG ketamine 50 mg

Study Locations (2)

California

  • Lotus Clinical Research, LLC - Pasadena

Utah

  • Prahealthsciences - Salt Lake City

Trial Details

FieldValue
Enrollment Target 120 participants
Start Date 2014-07
Est. Completion 2014-11
Phase Phase 2

Sponsor

Lotus Clinical Research

5 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02199678

The ClinicalTrials.gov registry entry for NCT02199678 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 304-participant average among 374 other Pain trials with a reported enrollment target (61% lower). The listed sponsor is Lotus Clinical Research, which has 5 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Pain appearing as the primary indexed condition, and to 4 interventions - of which Placebo is the first listed.

NCT02199678 reports 2 study locations spanning 2 distinct geographic areas - top geographies include California, Utah.

Frequently Asked Questions

What is clinical trial NCT02199678 about?

NCT02199678 is a clinical study titled "A Study to Assess the Analgesic Properties of a Sublingual Wafer Formulation of Ketamine Following Third Molar Extraction". This is a Phase 2, randomized, multicenter, parallel group, double-blind, dose-ranging, placebo-controlled evaluation of the analgesic efficacy, safety and pharmacokinetics of ketamine sublingual wafer in adult subjects who experience post operative pain after undergoing third molar extraction.

What is the current status of trial NCT02199678?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 120 participants. The study started on 2014-07. Estimated completion is 2014-11.

What conditions does trial NCT02199678 study?

This clinical trial studies the following conditions: Pain.

What interventions are being tested in trial NCT02199678?

The interventions under investigation include: Placebo (DRUG), ketamine 25 mg (DRUG), ketamine 35 mg (DRUG), ketamine 50 mg (DRUG).

Who is sponsoring clinical trial NCT02199678?

This trial is sponsored by Lotus Clinical Research, which has 5 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02199678 being conducted?

This trial has 2 study locations across California, Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Pain

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.